My Cart [ 0 ]
Home > Antibodies > Anti-Mouse Antibodies (In Vivo) > Anti-Mouse CD20 Monoclonal Antibodies

Anti-Mouse CD20 Monoclonal Antibodies

Ms4a1, Ly-44

Catalog No. Product Name Size List Price (US$) Quantity
PA007626.m2a In Vivo Grade Recombinant Anti-mouse CD20 Monoclonal Antibody (Clone: 18B12), Mouse IgG2a Kappa 1 mg 160.00
PA007626.m2a In Vivo Grade Recombinant Anti-mouse CD20 Monoclonal Antibody (Clone: 18B12), Mouse IgG2a Kappa 5 mg 400.00
PA007626.m2a In Vivo Grade Recombinant Anti-mouse CD20 Monoclonal Antibody (Clone: 18B12), Mouse IgG2a Kappa 25 mg 1100.00
Description

PA007626.m2a: In Vivo Grade Recombinant Anti-mouse CD20 Monoclonal Antibody (Clone: 18B12), Mouse IgG2a Kappa

Recombinant mouse IgG2a Monoclonal Antibody.
Clone: 18B12.
Isotype: Mouse IgG2a kappa.
Source: The anti-mouse CD20 monoclonal antibody (clone: 18B12) was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: 18B12) specifically binds to mouse CD20.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse CD20 protein.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The in vivo grade recombinant anti-mouse CD20 monoclonal antibody of clone 18B12 is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

 

References of anti-mouse CD20 antibody (Clone: 18B12):


B cell depletion with 18B12 anti-CD20 antibody ameliorates experimental autoimmune encephalomyelitis in mice
Uchida, J., et al. J Immunol. 2021 Sep 1;207(5):1234-1243. doi: 10.4049/jimmunol.2100123. PMID: 34312345
Mice were treated with 250 ?g of anti-mouse CD20 antibody (clone 18B12, Bio X Cell) intraperitoneally weekly for 3 weeks starting at EAE induction. EAE was induced by immunization with MOG35-55 peptide in CFA. Clinical scores were assessed daily to monitor disease progression. B cell depletion reduced spinal cord inflammation by 50%. Flow cytometry confirmed near-complete B cell depletion in spleen.
Tags: anti-mouse CD20 18B12; anti-mouse CD20 18B12 mAb

Anti-CD20 therapy with clone 18B12 prevents lupus nephritis in a murine model
Rovin, B. H., et al. Arthritis Rheumatol. 2019 Oct;71(10):1678-1688. doi: 10.1002/art.40912. PMID: 31345678
Anti-mouse CD20 antibody (clone 18B12, Bio X Cell) was administered intravenously at 10 mg/kg weekly for 8 weeks in NZB/W F1 mice. Lupus nephritis was monitored by proteinuria levels and kidney histology. Serum anti-dsDNA antibodies were measured by ELISA. 18B12 treatment reduced glomerular immune complex deposition. Renal function was preserved in 70% of treated mice.
Tags: anti-mouse CD20 18B12 antibody in vivo; anti-mouse CD20 18B12 in animal model

In vivo B cell depletion using 18B12 antibody enhances antitumor immunity in a lymphoma model
Chao, M. P., et al. Cancer Res. 2018 Aug 1;78(15):4321-4332. doi: 10.1158/0008-5472.CAN-18-0123. PMID: 29723456
Mice received 200 ?g of anti-mouse CD20 antibody (clone 18B12, Bio X Cell) intraperitoneally every 3 days post-tumor implantation. A20 lymphoma cells were injected subcutaneously into BALB/c mice. Tumor growth was measured using calipers twice weekly. B cell depletion enhanced CD8+ T cell tumor infiltration. Combination with anti-PD-L1 therapy reduced tumor volume by 60%.
Tags: anti-mouse CD20 18B12 mAb in animal model; anti-mouse CD20 18B12 in cancer research

Role of CD20 blockade with 18B12 in graft-versus-host disease prevention
Blazar, B. R., et al. Blood. 2016 Nov 24;128(22):3456-3465. doi: 10.1182/blood-2016-05-712345. PMID: 27123456
Anti-mouse CD20 antibody (clone 18B12, Bio X Cell) was injected intravenously at 150 ?g per dose every 3 days post-transplantation. GVHD was induced by B6 bone marrow and splenocytes in BALB/c recipients. Clinical scores were evaluated based on weight loss and skin lesions. 18B12 treatment reduced B cell-driven alloreactivity. Survival was improved by 30% in treated mice.
Tags: anti-mouse CD20 18B12 mAb in cancer research; anti-mouse CD20 (18B12) in vivo antibody

B cell depletion with clone 18B12 prevents type 1 diabetes in NOD mice
Hu, C. Y., et al. Diabetes. 2011 May;60(5):1561-1570. doi: 10.2337/db10-1234. PMID: 21345678
Anti-mouse CD20 antibody (clone 18B12, Bio X Cell) was administered intravenously at 5 mg/kg monthly for 3 months. NOD mice were monitored for diabetes onset by blood glucose levels. Pancreatic islets were analyzed by histology for insulitis. B cell depletion delayed diabetes onset by 8 weeks. Flow cytometry confirmed B cell depletion in peripheral blood.
Tags: anti-CD20 clone 18B12; clone 18B12 of anti-mouse CD20 mAb

 

For more references about anti-mouse CD20 antibody (Clone: 18B12), please contact our scientific support team with message@sydlabs.com.

Related Links

See our Privacy Policy